MRNADIS Trademark

Trademark Overview

On Wednesday, February 5, 2020, a trademark application was filed for MRNADIS with the United States Patent and Trademark Office. The USPTO has given the MRNADIS trademark a serial number of 88786305. The federal status of this trademark filing is REGISTERED as of Tuesday, August 16, 2022. This trademark is owned by Elpis Biopharmaceuticals. The MRNADIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services in the field of antibodies
mrnadis

General Information

Serial Number88786305
Word MarkMRNADIS
Filing DateWednesday, February 5, 2020
Status700 - REGISTERED
Status DateTuesday, August 16, 2022
Registration Number6821596
Registration DateTuesday, August 16, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2020

Trademark Statements

Goods and ServicesResearch and development services in the field of antibodies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, February 9, 2020
Primary Code042
First Use Anywhere DateTuesday, October 20, 2020
First Use In Commerce DateTuesday, October 20, 2020

Trademark Owner History

Party NameElpis Biopharmaceuticals
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameElpis Biopharmaceuticals
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameElpis Biopharmaceuticals
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Tuesday, August 16, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 16, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, July 12, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, July 9, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 12, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, March 21, 2022USE AMENDMENT FILED
Monday, April 11, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 21, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, September 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 20, 2021SOU EXTENSION 2 GRANTED
Monday, September 20, 2021SOU EXTENSION 2 FILED
Monday, September 20, 2021TEAS EXTENSION RECEIVED
Wednesday, March 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 22, 2021SOU EXTENSION 1 GRANTED
Monday, March 22, 2021SOU EXTENSION 1 FILED
Monday, March 22, 2021TEAS EXTENSION RECEIVED
Tuesday, September 22, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 20, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, June 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 12, 2020ASSIGNED TO LIE
Thursday, June 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 2, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, May 2, 2020NON-FINAL ACTION E-MAILED
Saturday, May 2, 2020NON-FINAL ACTION WRITTEN
Friday, April 24, 2020ASSIGNED TO EXAMINER
Thursday, March 26, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 26, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 26, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, February 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 8, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

mrnadis antibodies field services development research